Original Research
Published on 07 May 2026
Cost-effectiveness analysis based on two models of sacituzumab tirumotecan versus platinum-based chemotherapy as second-line treatment in EGFR-mutant non-small-cell lung cancer
in Health Economics
- 245 views
Original Research
Published on 07 May 2026
in Health Economics
Perspective
Published on 07 May 2026
in Augmented and Synthetic Neuroergonomics
Original Research
Published on 07 May 2026
in Animal Nutrition
Systematic Review
Published on 07 May 2026
in Digital Learning Innovations
Systematic Review
Published on 07 May 2026
in Health Technology Implementation
Original Research
Published on 07 May 2026
in Digital Public Health
Original Research
Published on 07 May 2026
in Genitourinary Surgery and Interventions
Original Research
Published on 07 May 2026
in Oral Health Promotion
Original Research
Published on 07 May 2026
in Elite Sports and Performance Enhancement
Original Research
Published on 07 May 2026
in Rehabilitation for Musculoskeletal Conditions
Original Research
Published on 07 May 2026
in Life-Course Epidemiology and Social Inequalities in Health
Review
Published on 07 May 2026
in Molecular Signalling and Pathways
Original Research
Published on 07 May 2026
in Health Technology Implementation
Review
Published on 07 May 2026
in Obstetrics and Gynecology
Original Research
Published on 07 May 2026
in Social Movements, Institutions and Governance
Editorial
Published on 07 May 2026
in Emotion Regulation and Processing